San Carlos, CA, United States of America

Jessica P Lao

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jessica P. Lao: Pioneering Engineered Acid Alpha-Glucosidase Variants

Introduction: Jessica P. Lao, an accomplished inventor based in San Carlos, California, has made significant contributions to the field of biochemistry through her innovative work on engineered acid alpha-glucosidase variants. With one notable patent to her name, she has paved the way for new therapeutic applications that hold the potential for substantial advancements in medical treatments.

Latest Patents: Jessica holds a patent for her invention titled "Engineered Acid Alpha-Glucosidase Variants." This patent encompasses engineered polypeptides that provide enhanced expression, stability at neutral pH, and increased activity in cell lysates. In her efforts to optimize these GAA polypeptides, the invention opens pathways for utilizing the compositions in various therapeutic contexts, showcasing her dedication to pushing the boundaries of biotechnological advancements.

Career Highlights: Currently, Jessica is a pivotal member of Codexis, Inc., a renowned company that specializes in biocatalysis and protein engineering. Her role within the company reflects her expertise and commitment to research and development. She has focused on harnessing and optimizing enzyme capabilities, contributing to the innovation landscape in biotechnology.

Collaborations: In her career at Codexis, Jessica has enjoyed collaborations with esteemed coworkers including William Casey Hallows and Rachel Cathleen Botham. These partnerships highlight the collaborative spirit prevalent in their research endeavors, fostering an environment where innovative ideas can flourish and lead to groundbreaking discoveries.

Conclusion: Jessica P. Lao exemplifies the spirit of innovation in the biotechnology sector. With her patent on engineered acid alpha-glucosidase variants, she not only showcases her inventiveness but also her commitment to improving therapeutic methods. As she continues to work alongside her talented colleagues, the future holds promise for even more advancements that may change the landscape of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…